Petros Pharmaceuticals, Inc. (PTPI): Form 8-K filed 2026-09-30

Items reported

Item 1.03: Bankruptcy or Receivership
A receiver, fiscal agent or similar officer was appointed for the company or its parent, or the company filed for bankruptcy protection (for example under Chapter 11).
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
An event, such as a default, caused a material financial obligation of the company to be accelerated or increased.
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
A director or a named officer (such as the CEO or CFO) left or was appointed, or certain executive compensation arrangements were adopted or changed.

Type	Description	Document
8-K	FORM 8-K	tm2626722d1_8k.htm

This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.